El sistema para llegar a millones de pacientes ya existe
Secondary endpoints included changes in total alcohol consumption, number of days without alcohol, number of drinks per drinking day, and craving, among others (these included various metabolic measures and biomarkers)
Recovery may also require an overnight hospital stay and follow-up visits, as well as weeks of restricted activity, compression garments and drains
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management
Monitoring and adjustment protocols should include: Weight and vital signs at each visit (initially monthly, then quarterly) Assessment of medication tolerance and adherence Evaluation of eating behaviors and physical activity Laboratory monitoring as outlined previously Reassessment of weight-related comorbidities Realistic expectations should be established through shared decision-making
A press release from the data intelligence company for healthcare explained that said industry grew by 2% in 2024 due to the increased use of GLP-1 medications
